"Original antigenic sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants

Maryam Noori¹, Seyed Aria Nejadghaderi^{2

3}, Nima Rezaei^{4

5

6}

Affiliations

¹ Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
² Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
³ School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁴ Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
⁶ Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Maryam Noori et al. Infect Control Hosp Epidemiol. 2022 Aug.

. 2022 Aug;43(8):1091-1092.

doi: 10.1017/ice.2021.199. Epub 2021 May 3.

Maryam Noori¹, Seyed Aria Nejadghaderi^{2

3}, Nima Rezaei^{4

5

6}

¹ Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
² Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
³ School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁴ Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
⁶ Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

No abstract available

References

1. Abdool Karim SS, de Oliveira T. New SARS-CoV-2 variants—clinical, public health, and vaccine implications. N Engl J Med 2021. doi: 10.1056/NEJMc2100362. - DOI - PMC - PubMed
1. Liu Y, Liu J, Xia H, et al. Neutralizing activity of BNT162b2-elicited serum. N Engl J Med 2021. doi: 10.1056/NEJMc2102017. - DOI - PMC - PubMed
1. Shen X, Tang H, Pajon R, et al. Neutralization of SARS-CoV-2 variants B.1.429 and B.1.351. N Engl J Med 2021. - PMC - PubMed
1. Wang G-L, Wang Z-Y, Duan L-J, et al. Susceptibility of circulating SARS- CoV-2 variants to neutralization. N Engl J Med 2021. doi: 10.1056/NEJMc2103022. - DOI - PMC - PubMed
1. Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 2021. doi: 10.1038/s41586-021-03398-2. - DOI - PubMed